For this study, Best Practices engaged 22 leaders from 16 biopharmaceutical companies and two medical device and health care firms through a benchmarking survey.
Only a third of participants in the study said they had seen slight or great improvement of call quality since deploying iPads to MSLs; 57% said call quality has stayed the same.
A majority of study participants said there had been an increase in the number of scientific presentations delivered since the deployment of iPads to MSLs, according to the study.
Best Practices serves biopharmaceutical and medical device companies worldwide. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
Airiver medical receives FDA approval for central airway stenosis trial
Talphera reaches enrollment milestone in NEPHRO CRRT pivotal trial
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions